CRYO-CELL INTL INC (CCEL) Stock Fundamental Analysis
USA - NYSEARCA:CCEL - US2288951088 - Common Stock
4.51 USD
+0.02 (+0.45%)
Overall CCEL gets a fundamental rating of 3 out of 10. We evaluated CCEL against 100 industry peers in the Health Care Providers & Services industry. CCEL has a medium profitability rating, but doesn't score so well on its financial health evaluation. CCEL does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year CCEL has reported negative net income.
CCEL had a positive operating cash flow in the past year.
CCEL had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CCEL had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.27%, CCEL is in line with its industry, outperforming 47.52% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.06%, CCEL is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CCEL is in line with the industry average of 9.48%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.27% | ||
| ROE | N/A | ||
| ROIC | 7.06% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
1.3 Margins
In the last couple of years the Profit Margin of CCEL has declined.
CCEL has a Operating Margin of 11.93%. This is amongst the best in the industry. CCEL outperforms 82.18% of its industry peers.
CCEL's Operating Margin has declined in the last couple of years.
The Gross Margin of CCEL (76.23%) is better than 90.10% of its industry peers.
CCEL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.93% | ||
| PM (TTM) | N/A | ||
| GM | 76.23% |
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CCEL is destroying value.
CCEL has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CCEL has more shares outstanding
Compared to 1 year ago, CCEL has an improved debt to assets ratio.
2.2 Solvency
CCEL has an Altman-Z score of 0.03. This is a bad value and indicates that CCEL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.03, CCEL is not doing good in the industry: 77.23% of the companies in the same industry are doing better.
CCEL has a debt to FCF ratio of 1.42. This is a very positive value and a sign of high solvency as it would only need 1.42 years to pay back of all of its debts.
The Debt to FCF ratio of CCEL (1.42) is better than 88.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.42 | ||
| Altman-Z | 0.03 |
ROIC/WACC0.6
WACC11.74%
2.3 Liquidity
A Current Ratio of 0.60 indicates that CCEL may have some problems paying its short term obligations.
CCEL's Current ratio of 0.60 is on the low side compared to the rest of the industry. CCEL is outperformed by 89.11% of its industry peers.
A Quick Ratio of 0.57 indicates that CCEL may have some problems paying its short term obligations.
The Quick ratio of CCEL (0.57) is worse than 86.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.57 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 94.34% over the past year.
CCEL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -29.04% yearly.
CCEL shows a small growth in Revenue. In the last year, the Revenue has grown by 2.05%.
CCEL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.11% yearly.
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
3.2 Future
CCEL is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -96.72% yearly.
Based on estimates for the next years, CCEL will show a decrease in Revenue. The Revenue will decrease by -0.09% on average per year.
EPS Next Y-100%
EPS Next 2Y-96.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.13%
Revenue Next 2Y-0.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CCEL. In the last year negative earnings were reported.
Also next year CCEL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
81.19% of the companies in the same industry are more expensive than CCEL, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCEL indicates a rather cheap valuation: CCEL is cheaper than 95.05% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.12 | ||
| EV/EBITDA | 7.49 |
4.3 Compensation for Growth
A cheap valuation may be justified as CCEL's earnings are expected to decrease with -96.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-96.72%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CCEL has a Yearly Dividend Yield of 19.31%, which is a nice return.
Compared to an average industry Dividend Yield of 2.49, CCEL pays a better dividend. On top of this CCEL pays more dividend than 100.00% of the companies listed in the same industry.
CCEL's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 19.31% |
5.2 History
CCEL has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The earnings of CCEL are negative and hence is the payout ratio. CCEL will probably not be able to sustain this dividend level.
DP-3067.58%
EPS Next 2Y-96.72%
EPS Next 3YN/A
NYSEARCA:CCEL (10/31/2025, 8:04:02 PM)
4.51
+0.02 (+0.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.28%
Inst Owner Change0%
Ins Owners40.67%
Ins Owner Change1.47%
Market Cap36.35M
Revenue(TTM)31.99M
Net Income(TTM)-171200
Analysts82.86
Price Target8.67 (92.24%)
Short Float %0.21%
Short Ratio0.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 19.31% |
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP-3067.58%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-0.9%
Revenue beat(4)0
Avg Revenue beat(4)-1.68%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-1.76%
Revenue beat(12)3
Avg Revenue beat(12)-0.51%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)N/A
EPS NY rev (3m)100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.14 | ||
| P/FCF | 6.12 | ||
| P/OCF | 5.81 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.49 |
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)0.74
FCFY16.33%
OCF(TTM)0.78
OCFY17.21%
SpS3.97
BVpS-1.93
TBVpS-2.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.27% | ||
| ROE | N/A | ||
| ROCE | 8.94% | ||
| ROIC | 7.06% | ||
| ROICexc | 7.88% | ||
| ROICexgc | 8.51% | ||
| OM | 11.93% | ||
| PM (TTM) | N/A | ||
| GM | 76.23% | ||
| FCFM | 18.56% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
ROICexc(3y)7.98%
ROICexc(5y)14.72%
ROICexgc(3y)8.63%
ROICexgc(5y)16.85%
ROCE(3y)9.64%
ROCE(5y)14.41%
ROICexgc growth 3Y-17.95%
ROICexgc growth 5Y-25.17%
ROICexc growth 3Y-16.74%
ROICexc growth 5Y-23.68%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.42 | ||
| Debt/EBITDA | 1.71 | ||
| Cap/Depr | 32.05% | ||
| Cap/Sales | 1% | ||
| Interest Coverage | 1.89 | ||
| Cash Conversion | 130.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.57 | ||
| Altman-Z | 0.03 |
F-Score7
WACC11.74%
ROIC/WACC0.6
Cap/Depr(3y)548.95%
Cap/Depr(5y)370.25%
Cap/Sales(3y)23.15%
Cap/Sales(5y)15.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.34%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-30.77%
EPS Next Y-100%
EPS Next 2Y-96.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%-2.99%
Revenue Next Year-0.13%
Revenue Next 2Y-0.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.29%
EBIT growth 3Y-9.92%
EBIT growth 5Y-12.52%
EBIT Next Year22.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y238.22%
FCF growth 3Y-15.98%
FCF growth 5Y-8.62%
OCF growth 1Y-28.52%
OCF growth 3Y-8.81%
OCF growth 5Y-1.01%
CRYO-CELL INTL INC / CCEL FAQ
What is the fundamental rating for CCEL stock?
ChartMill assigns a fundamental rating of 3 / 10 to CCEL.
Can you provide the valuation status for CRYO-CELL INTL INC?
ChartMill assigns a valuation rating of 2 / 10 to CRYO-CELL INTL INC (CCEL). This can be considered as Overvalued.
Can you provide the profitability details for CRYO-CELL INTL INC?
CRYO-CELL INTL INC (CCEL) has a profitability rating of 5 / 10.
What is the financial health of CRYO-CELL INTL INC (CCEL) stock?
The financial health rating of CRYO-CELL INTL INC (CCEL) is 3 / 10.